文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中国及全球膝关节骨关节炎负担:1990 - 2045年

Burden of knee osteoarthritis in China and globally: 1990-2045.

作者信息

Li Mingyang, Xia Qilin, Nie Qilong, Ding Ling, Huang Zhen, Jiang Zeping

机构信息

The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, 528051, China.

Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, No. 6, Qinren Road, Foshan, Guangdong, 528051, China.

出版信息

BMC Musculoskelet Disord. 2025 Jul 1;26(1):582. doi: 10.1186/s12891-025-08858-8.


DOI:10.1186/s12891-025-08858-8
PMID:40598022
Abstract

BACKGROUND: Knee osteoarthritis (KOA) is a major global health challenge, with rising prevalence, incidence, and disability-adjusted life years (DALYs). This disease increasingly burdens healthcare systems worldwide, particularly as populations age and obesity rates rise. In China, the rapid demographic shift towards an aging population, combined with rising obesity rates, makes KOA a pressing public health issue. China is projected to experience a significant increase in the number of elderly individuals, who are particularly vulnerable to KOA. Additionally, gender disparities, with women being more affected, add further urgency. Addressing KOA in China requires targeted healthcare strategies, considering these unique demographic and lifestyle factors. METHODS: We utilized data from the Global Burden of Disease (GBD) 2021 database to assess the prevalence, incidence, and DALYs related to KOA both globally and in China. The decomposition analysis was used to evaluate the contributions of population aging, growth, and epidemiological changes. For prediction, we employed the Bayesian Age-Period-Cohort (BAPC) model, implemented using the Integrated Nested Laplace Approximation (INLA) method, to project future trends from 2022 to 2045. RESULTS: From 1990 to 2021, both China and globally experienced significant increases in the burden of KOA. In China, the age-standardized prevalence rate (ASPR) increased from 4,667.29 (95% UI: 3,996.06-5,359.85) per 100,000 in 1990 to 5,016.52 (95% UI: 4,265.22-5,758.38) per 100,000 in 2021. Globally, the ASPR rose from 3,964.75 (95% UI: 3,411.86-4,536.4) per 100,000 in 1990 to 4,294.27 (95% UI: 3,695.04-4,910.76) per 100,000 in 2021. Similarly, the age-standardized incidence rate (ASIR) in China increased from 377.93 (95% UI: 324.79-434.28) per 100,000 in 1990 to 406.42 (95% UI: 348.7-467.23) per 100,000 in 2021, compared to a global increase from 330.26 (95% UI: 284.34-375.75) to 353.67 (95% UI: 304.56-402.5). The age-standardized DALY rate (ASDR) in China rose from 151.24 (95% UI: 72.96-291.47) per 100,000 in 1990 to 162.44 (95% UI: 78.35-314.13) per 100,000 in 2021, whereas the global ASDR rose from 127.14 (95% UI: 62.17-246.99) per 100,000 in 1990 to 137.59 (95% UI: 67.08-266.87) per 100,000 in 2021. The prevalence, incidence, and DALYs of KOA were consistently higher in females compared to males. In both regions, population growth had the most significant impact on KOA burden, but population aging was a more significant factor in China. High BMI and metabolic risk factors, particularly in females, were identified as key contributors to KOA-related DALYs. This study projects the trends in knee osteoarthritis (KOA) burden in China and globally by 2045. In China, the Age-Standardized Prevalence Rate (ASPR) is projected to increase by approximately 2.5% (from 5016.52 to 5142.90), while the Age-Standardized Incidence Rate (ASIR) is expected to decrease by about 8.8% (from 406.43 to 370.72). Globally, the ASPR is expected to rise by around 7.8% (from 4294.26 to 4630.97), while the ASIR is projected to increase by 5.8% (from 353.67 to 374.13). The Age-Standardized Death Rate (ASDR) is expected to increase in both China (by 1.3%, from 162.44 to 164.61) and globally (by 5.7%, from 137.59 to 145.45). These projections suggest an overall rise in the burden of KOA, with regional variations. CONCLUSION: KOA remains a significant and increasingly complex global health challenge, with its burden expected to rise sharply in the coming decades. This study highlights that in both China and globally, the escalating prevalence of KOA is closely linked to population aging and obesity, but the drivers vary across regions. In China, the rising burden is predominantly influenced by demographic aging, making it critical to develop targeted interventions that address the needs of an aging population. Globally, the expansion of the population is the primary contributor to the increased KOA burden, which underscores the importance of integrating KOA prevention into broader public health strategies aimed at managing population growth and associated lifestyle risks. The findings underscore the urgency of addressing obesity as a key risk factor for KOA, especially in women. Public health interventions should focus on obesity prevention, particularly in middle-aged and older populations, and include strategies such as promoting healthier diets, physical activity, and metabolic health management. Furthermore, policies aimed at improving joint health in aging populations, with a focus on early diagnosis and rehabilitation, could significantly alleviate the long-term societal and healthcare costs associated with KOA.

摘要

背景:膝关节骨关节炎(KOA)是一项重大的全球健康挑战,其患病率、发病率和伤残调整生命年(DALYs)呈上升趋势。这种疾病给全球医疗系统带来了越来越大的负担,尤其是随着人口老龄化和肥胖率上升。在中国,人口结构迅速向老龄化转变,加上肥胖率上升,使得KOA成为一个紧迫的公共卫生问题。预计中国老年人口数量将大幅增加,而老年人尤其容易患KOA。此外,性别差异也加剧了这一问题,女性受影响更为严重。鉴于这些独特的人口和生活方式因素,在中国应对KOA需要有针对性的医疗保健策略。 方法:我们利用全球疾病负担(GBD)2021数据库的数据,评估全球和中国与KOA相关的患病率、发病率和DALYs。采用分解分析来评估人口老龄化、增长和流行病学变化的贡献。为了进行预测,我们使用贝叶斯年龄-时期-队列(BAPC)模型,并采用集成嵌套拉普拉斯近似(INLA)方法,预测2022年至2045年的未来趋势。 结果:从1990年到2021年,中国和全球的KOA负担均显著增加。在中国,年龄标准化患病率(ASPR)从1990年的每10万人4667.29(95%UI:3996.06-5359.85)增至2021年的每10万人5016.52(95%UI:4265.22-5758.38)。在全球范围内,ASPR从1990年的每10万人3964.75(95%UI:3411.86-4536.4)升至2021年的每10万人4294.27(95%UI:3695.04-4910.76)。同样,中国的年龄标准化发病率(ASIR)从1990年的每10万人377.93(95%UI:324.79-434.28)增至2021年的每10万人406.42(95%UI:348.7-467.23),而全球则从每10万人330.26(95%UI:284.34-375.75)增至353.67(95%UI:304.56-402.5)。中国的年龄标准化伤残调整生命年率(ASDR)从1990年的每10万人151.24(95%UI:72.96-291.47)升至2021年的每10万人162.44(95%UI:78.35-314.13),而全球ASDR从1990年的每10万人127.14(95%UI:62.17-246.99)升至2021年的每10万人137.59(95%UI:67.08-266.87)。KOA的患病率、发病率和DALYs在女性中始终高于男性。在这两个地区,人口增长对KOA负担的影响最大,但在中国,人口老龄化是一个更重要的因素。高BMI和代谢风险因素,尤其是在女性中,被确定为与KOA相关的DALYs的关键因素。本研究预测了到2045年中国和全球膝关节骨关节炎(KOA)负担的趋势。在中国,年龄标准化患病率(ASPR)预计将增加约2.5%(从5016.52增至5142.90),而年龄标准化发病率(ASIR)预计将下降约8.8%(从406.43降至370.72)。在全球范围内,ASPR预计将上升约7.8%(从4294.26增至4630.97),而ASIR预计将增加5.8%(从353.67增至374.13)。年龄标准化死亡率(ASDR)预计在中国(增加1.3%,从162.44增至164.61)和全球(增加5.7%,从137.59增至145.45)均会上升。这些预测表明KOA负担总体呈上升趋势,且存在地区差异。 结论:KOA仍然是一个重大且日益复杂的全球健康挑战,预计其负担在未来几十年将急剧上升。本研究强调,在中国和全球,KOA患病率的不断上升与人口老龄化和肥胖密切相关,但驱动因素因地区而异。在中国,负担上升主要受人口老龄化影响,因此制定针对老年人口需求的有针对性干预措施至关重要。在全球范围内,人口增长是KOA负担增加的主要因素,这凸显了将KOA预防纳入旨在控制人口增长和相关生活方式风险的更广泛公共卫生战略的重要性。研究结果强调了将肥胖作为KOA关键风险因素加以应对的紧迫性,尤其是在女性中。公共卫生干预应侧重于预防肥胖,特别是在中老年人群中,并包括促进健康饮食、体育活动和代谢健康管理等策略。此外,旨在改善老年人群关节健康、注重早期诊断和康复的政策,可显著减轻与KOA相关的长期社会和医疗成本。

相似文献

[1]
Burden of knee osteoarthritis in China and globally: 1990-2045.

BMC Musculoskelet Disord. 2025-7-1

[2]
The global impact of non-alcoholic fatty liver disease (including cirrhosis) in the elderly from 1990 to 2021 and future projections of disease burden.

PLoS One. 2025-6-25

[3]
[Disease burden and future trend predictions of age-related hearing loss in China and worldwide from 1990 to 2021].

Beijing Da Xue Xue Bao Yi Xue Ban. 2025-6-18

[4]
Global, regional, and national burden of congenital anomalies of the kidney and urinary tract from 1990 to 2021, with projections to 2036: a systematic analysis of the global burden of disease study 2021.

BMC Nephrol. 2025-7-1

[5]
Global, regional, and national burden of endometriosis among women of childbearing age from 1990 to 2021: a cross-sectional analysis from the 2021 global burden of disease study.

Int J Surg. 2025-6-20

[6]
Rising incidence and clinical impact of kidney cancer in China and worldwide: a call for targeted prevention, early diagnosis, and equitable treatment.

Transl Androl Urol. 2025-5-30

[7]
Systematic analysis of gout burden among young adults in China from 1990 to 2021: findings from the global burden of disease study 2021.

Front Public Health. 2025-6-9

[8]
Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021.

Cancer Control. 2025

[9]
Global burden of gout and its changing trends and predictions in China: An analysis based on Global Burden of Disease Study 2021.

Chin Med J (Engl). 2025-7-2

[10]
Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet Glob Health. 2025-7

引用本文的文献

[1]
Effects of Tissue-Bone Homeostasis Manipulation at Different Time Points on Pain and Brain Mechanisms in Patients with Knee Osteoarthritis Based on Circadian Rhythm: Study Protocol for a Randomized Controlled Trial.

J Pain Res. 2025-8-19

[2]
Global, regional, and national burden of colorectal cancer in the elderly (aged > 60 years): a comprehensive analysis across 204 countries and territories (1990-2021)​.

BMC Gastroenterol. 2025-8-9

本文引用的文献

[1]
Global Burden of Osteoarthritis Attributable to High Body Mass Index, 1990 to 2021: Insights From the Global Burden of Disease Study 2021.

Arthritis Rheumatol. 2025-5-19

[2]
Epidemiological trends and characteristics of osteoarthritis in China during 1990-2021.

J Orthop Translat. 2025-3-17

[3]
Low-versus high-dose aspirin for venous thromboembolic prophylaxis after total joint arthroplasty: a systematic review and meta-analysis.

J Orthop Surg Res. 2024-12-19

[4]
Global, regional and national burden of osteoarthritis in 1990-2021: a systematic analysis of the global burden of disease study 2021.

BMC Musculoskelet Disord. 2024-12-19

[5]
Association between obesity measurement indexes and symptomatic knee osteoarthritis among the Chinese population: analysis from a nationwide longitudinal study.

BMC Musculoskelet Disord. 2024-12-2

[6]
Prevalence and risk factors of knee osteoarthritis: a cross-sectional survey in Nanjing, China.

Front Public Health. 2024

[7]
The Efficacy of Calcium Sulfate/Hydroxyapatite (CaS/HA) Gentamicin in Osteomyelitis Treatment: A Case Series.

Antibiotics (Basel). 2024-11-10

[8]
Leptin Promotes the Expression of Pro-inflammatory Mediator Genes but Does Not Alter Osteoclastogenesis and Early Stage Differentiation of Osteoblasts.

J Physiol Investig. 2024-11-1

[9]
One hundred-year secular trends of overweight and obesity in China: effects of age, period, and cohort.

Obesity (Silver Spring). 2024-11

[10]
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021.

EClinicalMedicine. 2024-9-24

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索